Clinical Research & Reference Standard Compendium
GHRP-6 Spray - Scientific Literature
I. Abstract & Overview
GHRP-6 is a synthetic hexapeptide agonist at the ghrelin receptor with a notable place in receptor pharmacology history: the peptide preceded the target. Bowers and colleagues characterized its growth hormone-releasing activity through the 1980s, publishing detailed pharmacology in 1991, and the receptor mediating that activity was cloned by Howard and colleagues only in 1996. Robinson and colleagues showed in 1992 that the growth hormone response operates independently of endogenous growth hormone-releasing hormone signaling, establishing it as a distinct pathway. Unlike the later selective secretagogue Ipamorelin, GHRP-6 also raises corticotropin, cortisol and prolactin and acts as an appetite-stimulating ghrelin mimetic, a broader profile that makes it the standard comparator in selectivity panels. Research Use Only (RUO).
II. Chemical Specifications
| Molecular Formula | C46H56N12O6 |
|---|---|
| Molar Mass | 873.0 g/mol (PubChem CID 9919153) |
| CAS Registry Number | 87616-84-0 |
| Amino Acid Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (6 residues; two tryptophans, two D-configured positions, C-terminal amide) |
III. Mechanism & Cellular Signaling Pathways
GHRP-6 activates the ghrelin receptor on pituitary somatotroph cells through a calcium-driven route. Receptor engagement couples via Gq to phospholipase C, which cleaves membrane phosphoinositides into inositol trisphosphate and diacylglycerol; inositol trisphosphate releases calcium from intracellular stores and the resulting transient drives fusion of growth hormone secretory vesicles. Research shows this pathway is independent of the GHRH receptor route, which Robinson and colleagues demonstrated by showing the response persists without endogenous GHRH signaling. What distinguishes GHRP-6 within its own class is breadth rather than selectivity: laboratory investigations report concurrent elevation of corticotropin, cortisol and prolactin, plus appetite stimulation consistent with its action as a ghrelin mimetic. Ipamorelin engages the same receptor without that accompanying profile, which is why the two are run together.
IV. Primary Research Directions
- **Selectivity Panel Comparator:** Research shows concurrent elevation of corticotropin, cortisol and prolactin alongside growth hormone, the broader profile against which selective secretagogues are benchmarked.
- **Calcium Mobilization Assays:** Studies indicate Gq-coupled signaling in cells expressing the ghrelin receptor, read as intracellular calcium flux rather than cAMP accumulation.
- **GHRH Independence Testing:** Robinson and colleagues (1992) showed the growth hormone response persists without endogenous GHRH signaling, establishing the two pathways as separable.
- **Receptor Discovery Reference:** Howard and colleagues (1996) cloned the receptor whose existence this peptide's pharmacology had implied, making GHRP-6 the historical reference agonist for the target.
- **Appetite Signaling Models:** Laboratory investigations use its ghrelin-mimetic appetite stimulation as a readout distinct from growth hormone release in feeding behaviour studies.
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- Bowers, C. Y., Sartor, A. O., Reynolds, G. A., et al. (1991). 'On the actions of the growth hormone-releasing hexapeptide, GHRP.' Endocrinology, 128(4), 2027-2035. DOI: 10.1210/endo-128-4-2027 | PMID: 2004615
- Howard, A. D., Feighner, S. D., Cully, D. F., et al. (1996). 'A receptor in pituitary and hypothalamus that functions in growth hormone release.' Science, 273(5277), 974-977. DOI: 10.1126/science.273.5277.974 | PMID: 8688086
- Robinson, B. M., Friberg, R. D., Bowers, C. Y., et al. (1992). 'Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone.' Journal of Clinical Endocrinology and Metabolism, 75(4), 1121-1124. DOI: 10.1210/jcem.75.4.1400881 | PMID: 1400881
GHRP-6 Spray
Abstract & Overview
GHRP-6 is a synthetic hexapeptide agonist at the ghrelin receptor with a notable place in receptor pharmacology history: the peptide preceded the target. Bowers and colleagues characterized its growth hormone-releasing activity through the 1980s, publishing detailed pharmacology in 1991, and the receptor mediating that activity was cloned by Howard and colleagues only in 1996. Robinson and colleagues showed in 1992 that the growth hormone response operates independently of endogenous growth hormone-releasing hormone signaling, establishing it as a distinct pathway. Unlike the later selective secretagogue Ipamorelin, GHRP-6 also raises corticotropin, cortisol and prolactin and acts as an appetite-stimulating ghrelin mimetic, a broader profile that makes it the standard comparator in selectivity panels. Research Use Only (RUO).
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.
Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (GHRP-6 Spray) | 5.80 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 5.80 minutes represents the active compound (GHRP-6 Spray). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
GHRP-6 activates the ghrelin receptor on pituitary somatotroph cells through a calcium-driven route. Receptor engagement couples via Gq to phospholipase C, which cleaves membrane phosphoinositides into inositol trisphosphate and diacylglycerol; inositol trisphosphate releases calcium from intracellular stores and the resulting transient drives fusion of growth hormone secretory vesicles. Research shows this pathway is independent of the GHRH receptor route, which Robinson and colleagues demonstrated by showing the response persists without endogenous GHRH signaling. What distinguishes GHRP-6 within its own class is breadth rather than selectivity: laboratory investigations report concurrent elevation of corticotropin, cortisol and prolactin, plus appetite stimulation consistent with its action as a ghrelin mimetic. Ipamorelin engages the same receptor without that accompanying profile, which is why the two are run together.
Primary Research Directions
**Selectivity Panel Comparator:** Research shows concurrent elevation of corticotropin, cortisol and prolactin alongside growth hormone, the broader profile against which selective secretagogues are benchmarked.
**Calcium Mobilization Assays:** Studies indicate Gq-coupled signaling in cells expressing the ghrelin receptor, read as intracellular calcium flux rather than cAMP accumulation.
**GHRH Independence Testing:** Robinson and colleagues (1992) showed the growth hormone response persists without endogenous GHRH signaling, establishing the two pathways as separable.
**Receptor Discovery Reference:** Howard and colleagues (1996) cloned the receptor whose existence this peptide's pharmacology had implied, making GHRP-6 the historical reference agonist for the target.
**Appetite Signaling Models:** Laboratory investigations use its ghrelin-mimetic appetite stimulation as a readout distinct from growth hormone release in feeding behaviour studies.
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
Bowers, C. Y., Sartor, A. O., Reynolds, G. A., et al. (1991). 'On the actions of the growth hormone-releasing hexapeptide, GHRP.' Endocrinology, 128(4), 2027-2035. DOI: 10.1210/endo-128-4-2027 | PMID: 2004615
Howard, A. D., Feighner, S. D., Cully, D. F., et al. (1996). 'A receptor in pituitary and hypothalamus that functions in growth hormone release.' Science, 273(5277), 974-977. DOI: 10.1126/science.273.5277.974 | PMID: 8688086
Robinson, B. M., Friberg, R. D., Bowers, C. Y., et al. (1992). 'Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone.' Journal of Clinical Endocrinology and Metabolism, 75(4), 1121-1124. DOI: 10.1210/jcem.75.4.1400881 | PMID: 1400881
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
